Journal article · Vestibular← The news desk

✦ The Dispatch

Contemporary diagnosis and management of vestibular migraine: a systematic review of conventional and CGRP-targeted therapies

A dispatch from PubMed — filed

Vestibular migraine (VM) is a common cause of recurrent episodic vertigo, and it is associated with significant disability from recurrent vestibular and migraine symptoms. While there are a number of standard preventive treatments, their effectiveness is quite variable, and new treatments which target calcitonin gene-related peptide (CGRP) have been identified as potential treatments....

Continue reading at PubMed

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

CGRP-targeted therapies show emerging promise for vestibular migraine; audiologists and vestibular specialists should be aware of this evolving treatment landscape when collaborating with neurology, though prescribing decisions remain with physicians.

✦ Why It Matters ✦

A systematic review of CGRP-targeted therapies for vestibular migraine marks a significant step toward evidence-based treatment guidance for a condition that audiologists and vestibular specialists frequently co-manage.

✦ Key Points ✦
  1. 01Systematic review covers both conventional and CGRP-targeted therapies for vestibular migraine.
  2. 02CGRP-targeted agents represent a newer pharmacological class being evaluated for vestibular migraine management.
  3. 03Diagnostic criteria and clinical workup approaches for vestibular migraine are summarized.
  4. 04Review published in Frontiers in Neurology, a peer-reviewed open-access journal.
  5. 05Findings may help standardize multidisciplinary management of vestibular migraine.
✦ Claims & Evidence ✦

CGRP-targeted therapies are effective or beneficial in the management of vestibular migraine.

studypartially supported

Conventional therapies remain a standard approach in vestibular migraine management.

guidelinesupported
✦ Research metadata ✦
PMID
43010986
DOI
10.3389/fneur.2026.1951810.
Journal
Frontiers in Neurology
Publication type
systematic_review
Evidence level
1a
Population
Patients diagnosed with vestibular migraine across included studies
Intervention
Conventional therapies and CGRP-targeted therapies for vestibular migraine
Comparator
Conventional (non-CGRP) pharmacological and non-pharmacological treatments

Primary outcomes

Diagnostic accuracy and criteria for vestibular migraine; Efficacy of conventional treatments; Efficacy and safety of CGRP-targeted therapies

✦ Related stories ✦